Prediction of response to IVIg treatment in patients with lower motor neurone disorders

European Journal of Neurology

Volumn 13, Issue 2, 2006, Pages 135-140

  Strigl Pill, N ^a   Konig A ^b   Schroder M ^a   Beranek, H ^b   Schoser, B G H ^a   Spaeth, M ^a   Pongratz, D ^a   Muller Felber W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Amyotrophic lateral sclerosis; IVIg; Multifocal motor neuropathy; Treatment

Indexed keywords

CREATINE KINASE; GANGLIOSIDE GM1; IMMUNOGLOBULIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTONOMIC DENERVATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROMYOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; MALE; MULTIFOCAL MOTOR POLYNEUROPATHY; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROMUSCULAR FUNCTION; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PATIENT CODING; POLYNEUROPATHY; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT RESPONSE;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CREATINE KINASE; ELECTROMYOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33645238577     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01142.x     Document Type: Article

References (22)

1. Parry GJ Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988 11 103 107.
2. Pestronk A Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 1997 49 1289 1292.
3. Niebroj-Dobosz I Janik P Kwiecinski H. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes. Eur J Neurol 2004 11 13 16.
4. Nobile-Orazio E Meucci N Barbieri S et al. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993 43 537 544.
5. Katz JS Barohn RJ Kojan S et al. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology 2002 58 615 620.
6. Kaji R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 2003 27 285 296.
7. Taylor BV Dyck PJB Engelstad J et al. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 2004 63 129 137.
8. Traynor JB Codd MB Corr B et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airline House diagnostic criteria. Arch Neurol 2000 57 1171 1176.
9. Medical Research Council. Aids to the Examination of the Peripheral Nervous System. London, UK Her Majesty's Stationery Office 1976 1 2.
10. Soueidan SA Dalakas MC. Treatment of inclusion body myositis with high-dose intravenous immunoglobulin. Neurology 1993 43 876 879.
11. Taylor BV Gross L Windebank AJ. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 1996 47 951 955.
12. Berg-Vos RM Franssen H Wokke JH et al. Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol 2000 48 919 926.
13. Olney RK Lewis RA Putnam TD et al. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003 27 117 121.
14. Ellis CM Leary S Payan J et al. Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 1999 67 15 19.
15. Bouche P Moulonguet A Younes-Chennoufi AB et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995 59 38 44.
16. Van den Berg LH Franssen H Wokke JH. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 1998 121 421 428.
17. Taylor BV Wright RA Harper CM et al. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 2000 23 900 908.
18. Federico P Zochodne DW Hahn AF et al. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 2000 55 1256 1262.
19. Edmonds PJ Ziegler DK. Diagnostic value of serum creatine phosphokinase in motor neuron disease. South Med J 1975 68 1388 1390.
20. Le Forestier N Chassande B Moulonguet A et al. Multifocal motor neuropathies with conduction blocks. 39 cases. Rev Neurol (Paris) 1997 153 579 586.
21. Kornberg AJ Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. Ann Neurol 1995 37 Suppl. 1 S43 S50.
22. Carpo M Allaria S Scarlato G et al. Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy. Neurology 1999 53 2206 2207.